Serum Neopterin and complex stenosis morphology in patients with unstable angina

Journal of the American College of Cardiology

Volumn 35, Issue 4, 2000, Pages 956-962

  Garcia Moll, Xavier ^a   Coccolo, Fabio ^a   Cole, Della ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GAMMA INTERFERON; NEOPTERIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; BLOOD VESSEL; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; REGRESSION ANALYSIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; NEOPTERIN; PROGNOSIS;

EID: 0034654628     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00640-3     Document Type: Article

References (37)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease in the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
2. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s. Nature. 362:1993;801-809.
3. Moreno P.R., Falk E., Palacios I.F., et al. Macrophage infiltration in acute coronary syndromes implications for plaque rupture. Circulation. 90:1994;775-778.
4. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
5. Davies M.J. Stability and instability two faces of coronary atherosclerosis. Circulation. 94:1996;2013-2020.
6. Falk E. Morphological features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 63:1989;114E-120E.
7. Dollery C.M., McEwan J.R., Henney A. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
8. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
9. Neri Serneri G.G., Abbate R., Gori A.M., et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 86:1992;790-797.
10. Huber C., Batchelor R., Fuchs D., et al. Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma. J Exp Med. 160:1984;310-316.
11. Gupta S., Fredericks S., Schwartzman R.A., et al. Serum neopterin in acute coronary syndromes. (letter) Lancet. 349:1997;1252-1253.
12. Schumacher M., Halwachs G., Tatzber F., et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol. 30:1997;703-707.
13. Hussain K.M., Gould L., Bharathan T., et al. Arteriographic morphology and intracoronary thrombus in patients with unstable angina, non-Q wave myocardial infarction and stable angina pectoris. Angiology. 46:1995;181-189.
14. Kaski J.C., Chester M.R., Chen L., Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris the role of complex stenosis morphology. Circulation. 92:1995;2058-2065.
15. Chester M.R., Chen L., Tousoulis D., et al. Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. J Am Coll Cardiol. 25:1995;837-842.
16. Buchalter M.B., Been M., Williams D.O., et al. The occurrence of early sudden coronary artery occlusion following angioplasty may be predicted from the clinical characteristics of the patients and their coronary lesion morphology. Jpn Heart J. 33:1992;295-302.
17. Braunwald E. Unstable angina a classification. Circulation. 80:1989;410-414.
18. Sullivan D.R., Marwick T.H., Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 119:1990;1262-1279.
19. Schwartzman R.A., Cox I.D., Poloniecki J., et al. Elevated plasma lipoprotein (a) is associated with coronary artery disease in patients with chronic stable angina pectoris. J Am Coll Cardiol. 31:1998;1260-1266.
20. Kaski J.C., Chen L., Chester M. Rapid angiographic progression of "target" and "nontarget" stenoses in patients awaiting coronary angioplasty. J Am Coll Cardiol. 26:1995;416-421.
21. Chen L., Chester M., Redwood S., et al. Angiographic stenosis progression and coronary events in patients with "stabilised" unstable angina. Circulation. 91:1995;2319-2324.
22. Ambrose J.A., Winters S.L., Stern A., et al. Angiographic morphology and the pathogenesis of unstable angina. J Am Coll Cardiol. 5:1985;609-616.
23. Werner E.R., Bichler A., Daxenbichler G., et al. Determination of neopterin in serum and urine. Clin Chem. 33:1987;62-66.
24. Gurfinkel E.P., Scirica B.M., Bozovich G., et al. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q wave acute myocardial infarction. Am J Cardiol. 83:1999;515-518.
25. Wilson R.F., Holida M.D., White C.W. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation. 73:1986;286-293.
26. Neri Serneri G.G., Prisco D., Martini F., et al. Acute T-cell activation is detectable in unstable angina. Circulation. 95:1997;1806-1812.
27. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
28. Caligiuri G., Liuzzo G., Biasucci L.M., Maseri A. Immune system activation follows inflammation in unstable angina pathogenetic implications. J Am Coll Cardiol. 32:1998;1295-1304.
29. De Servi S., Mazzone A., Ricevuti G., et al. Clinical and angiographic correlates of leukocyte activation in unstable angina. J Am Coll Cardiol. 26:1995;1146-1150.
30. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 3:1996;213-229.
31. Miller M., Seidler A., Moalemi A., Pearson T.A. Normal triglyceride levels and coronary artery disease events the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol. 31:1998;1252-1257.
32. Phillips N.R., Waters D., Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88:1993;2762-2770.
33. Ericsson C.-G., Hamsten A., Nilsson J., et al. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet. 347:1996;549-553.
34. Frick M.H., Syvanne M., Nieminen M.S., et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation. 96:1997;2137-2143.
35. Zajtchuk R., Zajtchuk K. Relationship of triglyceride levels to thrombosis in patients with coronary artery disease. Ann Thorac Surg. 35:1983;274-276.
36. Kaski J.C., Chen L., Crook R., et al. Coronary stenosis progression differs in patients with stable angina pectoris with and without a previous history of unstable angina. Eur Heart J. 17:1996;1488-1494.
37. Kaski J.C. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol. 31:1998;523-526.